University of Missouri

Gary Clark

Peter Sutovsky

Breton F Barrier

The present disclosure provides a novel therapeutic vaccine approach that triggers a therapeutic antitumor response. The inventive approach is to selectively eliminate the carbohydrate sequences from tumor cells without affecting the tumor associated protein epitopes.

Cancer immune-based therapy

The present invention provides a new apparatus/system for determining fertility of mammalian sperm based on a specific sperm-binding test that mimics sperm binding to an egg. The inventive apparatus/system comprises surface-modified beads with a compound or conjugates containing a carbohydrate sequence associated with the mammalian zona-pellucida (ZP) glycoproteins.

Methods and reagents for evaluating the binding of mammalian sperm

In various cases, an obstetrical device is provided for assisting a cesarean section delivery of a neonate having a fetal presenting part well seated within the mother's pelvis. Generally, the device comprises a tubular tail having an internal lumen and a hollow head extending from a distal end of the tail and having an internal chamber fluidly connected to the lumen. The head includes at least one aperture extending through an exterior wall. The device is operable to position the head near or in contact with the fetal presenting part to provide air into an area near and/or between contact surfaces of the fetal presenting part and a vagina and/or a cervix of the mother. Providing the air will reduce or release a suction formed between the contact surfaces such that the well seated fetal presenting part can be easily separated from the vagina and/or the cervix.

Growing community of inventors

Columbia, MO, United States of America

Gary Clark